This is in regards to the pharma Ipsen...
They are trialing a drug called Elafibranor. It is being used for treatment in PBC, biliary atresia (in children) , PSC, Alagille Syndrome, and Primary Familial Cholestasis.
With patients taking Urso, often up to 40% do not see improvement. 3-5% of patients can't take it for various reasons. Those on Ocaliva, greater than 50% don't see an improvement.
161 people were trialed. There was a placebo group used for half of them.
They saw decreased alk phos and bilirubin. 51% had decreased alk phos after 1 year. 15% had completely normal lab results. Improvement was seen after 4 weeks in some patients.
Using the Itch Numeric Rating Scale - according to this scale: no itching = 0, mild 1-3 points, moderate 4-6 points, severe 7-8 points, and very severe pruritis (greater than or equal to 9 points.
On this scale a decrease of 1.9 points was seen for those with a
5-10 points score. With a placebo, a decrease of 1.1 points seen.
With those whose itching was in the 0-5 category, there was a decrease of 4.2 points overall. Those with a score 6-10 on the scale, there was a decrease of 1.9, and in the placebo group a decrease of 1.1 points.
The common side effects seen were nausea and vomiting, abdominal pain, and diarrhea.
Ipsen is clearly committed to the disease of PBC. Right now they are working on 2 projects.
1. The patients experience map... and 2. barriers to patients in their health care. They are interested in why certain information isn't being given to patients and also why certain questions aren't being asked. ie. "how is your itch?" "what seems to help with it".....
I was truly impressed with their commitment to making our lives better.
I know for me personally, I have never in the last 3 years, since my PBC has returned, if I was itching or feeling that fatigue again. Have you been asked these questions by your doctor? What would you hope they would ask?!